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I. INTRODUCTION
LIVER ANATOMY 
 Liver is located in the upper right-hand portion of the abdominal cavity,  beneath the 
diaphragm, and on top of the stomach, right kidney, and intestines. Shaped like a cone, 
the liver is a dark reddish-brown organ that weight about 3 pounds.
There are two distinct sources that supply blood to the liver, including the following:
• oxygenated blood flows in from the hepatic artery 
• nutrient-rich blood flows in from the hepatic portal vein 
The liver holds about one pint (13 percent) of the body's blood supply at any given moment. The liver 
consists of two main lobes, both of which are made up of thousands of lobules. These lobules are connected 
to small ducts that connect with larger ducts to ultimately form the hepatic duct. The hepatic duct transports 
the bile produced by the liver cells to the gallbladder and duodenum (the first part of the small intestine). If 
the liver is not working efficiently and antioxidant defenses are low, the effects can be seen in any cell, 
tissue or organ in the body. A vast constellation of symptoms can result from impaired liver function that at 
first glance may seem to have nothing at all to do with the liver. 
PHYSIOLOGICAL FUNCTIONS OF THE LIVER
                             The liver regulates most chemical levels in the blood and excretes a 
product called bile, which helps carry away waste products from the liver. All the blood 
leaving the stomach and intestines passes through the liver. The liver processes this blood 
and breaks down the nutrients and drugs into forms that are easier to use for the rest of 
the body. 
  
                                          FIG. 1 Anatomy of Liver
More than 500 vital functions have been identified with the liver. Some of the more well-
known functions include the following: 
• Production of bile, which helps carry away waste and break down fats in the small 
intestine during digestion 
• Production of certain proteins for blood plasma 
• Production of cholesterol and special proteins to help carry fats through the body
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• Conversion of excess glucose into glycogen for storage (glycogen can later be 
converted back to glucose for energy) 
• Regulation of blood levels of amino acids,  which form the building blocks of 
proteins 
• Processing of hemoglobin for use of its iron content (the liver stores iron) 
• Conversion of  poisonous ammonia  to  urea  (urea  is  an end product  of  protein 
metabolism and is excreted in the urine) 
• Clearing the blood of drugs and other poisonous substances 
• Regulating blood clotting 
• Resisting infections by producing immune factors and removing bacteria from the 
bloodstream 
               The liver is involved in a wide array of metabolic activities and it requires a large amount of  
energy and nutrients to accomplish these effectively. Over the last century, the workload of our livers has 
increased significantly.  A vast amount of chemicals are now in everyday use and all of these must be 
processed  and  neutralized  by  the  liver.  These  chemicals  come  in  the  form  of  pharmaceutical  drugs, 
household cleaning products, cosmetic, personal care products and building materials. 
HEPATOTOXICITY
 
                        FIG.2-STRUCTURAL CHANGES DURING LIVER INJURY
               
   
 
 
Types of hepatotoxicity
• Chemical induced 
• Drug induced 
• Viral hepatitis 
Chemical induced hepatotoxicity 
There are many reasons including the fact that the liver is the first major organ to 
be exposed to ingested chemicals due to its portal blood supply.
• Although chemicals are delivered to the liver to be metabolized and excreted, this 
can frequently lead to activation and liver injury.
• Study  of  the  liver  has  been  and  continues  to  be  important  in  understanding 
fundamental molecular mechanisms of toxicity as well as in assessment of risks to 
humans. (1)
Examples  of  acute  hepatotoxicity  chemicals:  Carbon  tetrachloride, 
Dimethylnitrosamine, Aflatoxin, Beryllium, Allyl alcohol, D-galactosamine, lead all this 
chemical having a mechanism to propagating the reactive oxygen species in hepatocytes. 
Drug induced hepatotoxicity 
The  acute  hepatotoxicity  effects  induced  by  drug  overdose  are  related  to 
formation of the toxic metabolite  by cytochrome P450-dependent  enzyme systems,  in 
concentrations  greater  than  can  be  detoxified  by  endogenous  GSH  levels,  and  the 
subsequent depletion of GSH cellular stores results in liver damage.  Reactive oxygen 
species  (ROS)  produced  by  oxidative  stress  play  an  important  role  in  pathological 
changes in the liver, particularly in cases of drug indued hepatotocity (2). Oxidative stress 
might represent abnormal that potentially involves dynamics of a disease as handling of 
oxygen that is primarily available to the characterized clinically and pathologically  (3). 
Oxidative stress as indicated by altered muscle glutathione levels and an increase in both 
protein oxidations and lipid peroxidation. (3)
  Examples  of  acute  hepatotoxicity  drugs:  NSAIDs  (paracetamol),  antibiotic 
(erythromycin),  Anti-tuberculosis  (isoniazid,  rifapicin),  immunosuppressive  drugs 
(Azathioprine, cyclophosphamide)  
Viral hepatitis 
Hepatitis  is an inflammation of the liver,  which is linked to an infection by a 
virus. There are at least five forms of viral hepatitis, each relating to a group of viruses 
like  hepatitis  A, B, C, D, and E in this  group hepatitis  C virus having a property to 
generate the oxidative mediated liver injury. Hepatitis C virus (HCV) is one of the main 
causative agents of chronic viral hepatitis. Chronic hepatitis C can progress to cirrhosis 
and  eventually  to  hepatocellular  carcinoma  over  a  period  of  20  to  30  years.  The 
mechanisms  by  which  HCV  causes  cell  damage  are  not  well  understood.  Different 
mechanisms  including  immunological  liver  damage,  direct  cytotoxicity  mediated  by 
different viral product and inductions of oxidative stress have been suggested as playing a 
pathogenic role in this infection. It has been suggested that HCV may cause oxidative 
stress in infected cell.  Several lines of evidence support this contention,  including the 
existence  of  activated  glutathione  turnover,  the  presence  of  increased  levels  of  lipid 
peroxidation  products  and  augmented  iron  stores  in  the  liver,  and  the  finding  of 
diminished  reduced  glutathione  values  in  peripheral  blood  mononuclear  cells  and 
erythrocytes. Moreover, it has been showed that patients with chronic hepatitis C exhibit 
an increased production of tumor necrosis factor-α (TNF-α), a cytokine that can produce 
oxidative stress by simulating the generation of reactive oxygen species (ROS) such as 
superoxide ion (O2.-) and hydrogen peroxide (H2O2). ROS can damage cells by causing 
lipid peroxidation, and oxidative damage of DNA and proteins, and by depleting ATP 
stores. In the presence of metals (such as Fe 3+), O2- can react with H2O2 to generate a 
hydroxyl radical than become even more reactive and cytototoxic than O2- or H2O2 (4).
OXIDATIVE STRESS
Oxidative stress is the in appropriate exposure to reactive oxygen species (ROS) 
and results  from the imbalance between pro oxidants and antioxidants  leading to cell 
damage (damage of lipids, proteins, carbohydrates and nucleic acids) and tissue injury. 
Oxidative stress is associated to many diseases such as diabetes, atherosclerosis, arthritis, 
neurodegenerative  disorders,  cancer  and  most  liver  diseases,  including  chronic  viral 
hepatitis,  alcoholic hepatitis,  non-alcoholic fatty liver disease (NAFLD), non-alcoholic 
steato hepatitis (NASH) and chronic homeostasis. In liver diseases, excess of ROS can 
induce hepatocytes cell death by either apoptosis or necrosis, leading to liver injury and 
loss of liver function.
Oxidative stress is a multi-stressor event involving numerous oxidizing species. 
Among them, reactive oxygen species (ROS) play a major part because they are highly 
reactive and formed by numerous enzymes. From a chemist’s perspective, the formation 
and reactivity of ROS is rather intriguing. Molecular oxygen in air is triplet dioxygen; 
although it is a diradical, and requires a total of four electrons for reduction to water, it 
reacts slowly with many biomolecules (e.g. DNA, proteins and membranes). If reduced, 
however, O2 is turned into highly aggressive ROS, which are more reduced yet, at the 
same time,  more  oxidizing  than  triplet  oxygen.  One-electron  reduction  results  in  the 
superoxide radical anion (O2K), two-electron reduction in hydrogen peroxide (H2O2) and 
three electron reduction in the highly destructive hydroxyl radical (HO-). This reductive 
activation of oxidizing species, in many ways the mirror image of oxidative activation of 
reducing  species,  occurs  as  a  ‘by-product’  of  normal  energy  metabolism  (enzymatic 
reduction of O2 to oxygen species ‘electronically short’ of water) or intentionally during 
host  defense  and  inflammatory  responses  (activity  of  peroxidase  enzymes).  ROS are 
frequently  converted  into  each  other,  for  example,  superoxide  into  peroxide  (by 
dismutase  enzymes)  and  peroxide  into  hydroxyl  radicals  (a  metal-catalyzed  Fenton 
reaction). Reactions of ROS with themselves or other molecules also result in secondary 
reactive species, such as peroxynitrite (ONOOK), the condensation product of superoxide 
and nitric oxide radicals (NO, a so-called ‘reactive nitrogen species’), and   a      range of 
reactive  sulfur  species  formed  from  ROS  and  cysteine  residues.   Apart  from  other 
stressors, ROS also react with antioxidants (which ‘neutralize’ the threat posed by them) 
and attack redox sensitive biomolecules. Reaction with these ‘targets’ results in the cell 
damage frequently associated with oxidative stress. These targets are stressor specific and 
include  cysteine  proteins,  membranes  and  DNA.  HO- might  be  the  species  with  the 
widest  range  of  targets;  it  is  known  to  oxidize  and  fragment  proteins,  hydroxylate 
aromatic rings in proteins and DNA and cause single-strand breaks in DNA (5).
CELL DEATH AND LIVER DISEASES
 Both necrotic and apoptotic cell death often occur in the same tissue and even the 
same cell  simultaneously (6). Necrosis  is passive and associated with ATP depletion, 
rupture  of  the  plasma  membrane  and  spilling  of  the  cellular  content  eliciting 
inflammation.  In  contrast,  apoptosis,  or  programmed  cell  death  is  an  active  process 
characterized by cell shrinkage, chromatin condensation, formation of apoptotic bodies 
(small membrane-surrounded cell fragments) and activation of caspases (7, 8). Apoptosis 
represents a regulated form of cell  death and it  is important in processes such as cell 
selection  during  development,  immunologic  responses  and  homeostasis.  Deregulated 
apoptosis contributes to pathologic states. The strict  regulation of apoptotic cell  death 
allows therapeutic intervention strategies. 
                 Apoptosis, or programmed cell  death,  is a normal  component of the  
development and health of multicellular organisms. Cells die in response to a variety of 
stimuli and during apoptosis they do so in a controlled, regulated fashion. This makes 
apoptosis distinct from another form of cell death called necrosis in which uncontrolled 
cell  death leads to lyses  of cells,  inflammatory responses and  potentially  to serious 
health problems. Apoptosis, by contrast, is a process in which cells play an active role in 
their own death (which is why apoptosis is often referred to as cell suicide).
During acute  and chronic liver  diseases,  hepatocytes  are  exposed to  increased 
levels  of oxidative stress,  cytokines  and bile  acids.  Hepatocytes  have highly efficient 
detoxification mechanisms and an enormous capacity to defend themselves against these 
agents, however, over-exposure to high levels of ROS perturbs the normal redox balance 
and shift cells  into a state of oxidative stress, resulting in cell  death.  Under oxidative 
stress conditions, the mode of cell death is primarily dependent on the variety of ROS, 
the  cell  type  and  the  specific  condition  of  ATP content  in  the  cell.  Therefore,  it  is 
important to know the mechanisms leading to hepatocytes cell  death, because a more 
complete understanding of the cellular response to oxidative stress could be of significant 
relevance to comprehend and treat liver diseases. 
Mitochondria-mediated apoptosis
Mitochondria play an important role in the regulation of cell death. They contain 
many  pro-apoptotic  proteins  such  as  Apoptosis  Inducing  Factor  (AIF), 
Smac/DIABLOand  cytochrome  C.  These  factors  are  released  from the  mitochondria 
following the formation of a pore in the mitochondrial membrane called the Permeability 
Transition Pore or PT pore. These pores are thought to form through the action of the 
proapoptotic  members  of  the  bcl-2  family  of  proteins,  and  Bax  which  in  turn  are 
activated by apoptotic signals such as cell stress, free radical damage or\growth factor 
deprivation. Mitochondria also play an important role in amplifying the apoptotic depend 
on the balance of pro- and anti-apoptotic bcl-2 proteins. When there is an excess of pro-
apoptotic proteins the cells are more sensitive to apoptosis, when there is an excess of 
anti-signaling from the death receptors, with receptor recruited caspase8 activating the 
pro-apoptotic bcl-2 protein, Bid.
Role of BCl-2 proteins in apoptosis 
The bcl-2 proteins are a family of proteins involved in the response to apoptosis. Some 
of these proteins (such as bcl-2and bcl-XL) are anti-apoptotic, while others (such as Bad, 
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of  the  mitochondria  where  the  anti-apoptotic  proteins  are  located.  This  interaction 
between pro and anti-apoptotic proteins disrupts the normal function of the anti-apoptotic 
bcl-2 proteins and can lead to the formation of pores in the mitochondria and the release 
of cytochrome C and other pro-apoptotic molecules from the inter membrane space. This 
in  turn  leads  to  the  formation  of  the  apoptosome  and  the  activation  of  the  caspase 
cascade. The release of cytochrome C from the mitochondria is a particularly important 
event in the induction of apoptosis. Once cytochrome C has been released into the cytosol 
it is able to interact with a protein called Apaf-1. This leads to the recruitment of pro-
caspases  9  into  a  multiprotein  complex  with  cytochrome  C  and  Apaf-1  called  the 
apoptosome.  Formation  of  the  apoptosome leads  to  activation  of  caspases  9  and  the 
induction of apoptosis (9).
ANTIOXIDANT  
                            Antioxidants protect us because they can scavenge ROS before they 
cause damage to the various biological  molecules,  or prevent  oxidative  damage from 
spreading,  e.g.  by  interrupting  the  radical  chain  reaction  of  lipid  peroxidation.  The 
antioxidant  defense systems in the human body are extensive and consist  of multiple 
layers, which protect at different sites and against different types of ROS. An important 
part  of  the  antioxidant  defense  system  inside  cells  is  the  antioxidant  enzymes.  For 
example,  superoxide  dismutase  scavenges  superoxide  and converts  it  to  less  reactive 
species. It was recently discovered that the gene for superoxide dismutase is defective in 
patients with amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's disease. 
The  very  existence  of  superoxide  dismutase  in  biological  systems,  as  well  as  other 
antioxidant enzymes (e.g., catalase, glutathione peroxidase) attests to the importance of 
oxidative  damage  as  a  real  threat  to  cellular  and  organismal  survival.  Otherwise, 
organisms  would  not  go  through  the  considerable  trouble  and energy expenditure  of 
evolving and synthesizing these enzymes. In addition to the antioxidant enzymes, there 
are several small-molecule antioxidants that play important roles in antioxidant defense 
systems. These small-molecule antioxidants are particularly important in blood and the 
fluids present in the extra cellular space, where antioxidant enzymes are absent or present 
only in small quantities. The small-molecule antioxidants include lipid-soluble and water-
soluble antioxidants. The lipid-soluble antioxidants are localized to cellular membranes 
and lipoproteins, whereas the water-soluble antioxidants are present in aqueous fluids, 
such as blood and the fluids within cells  and surrounding them.   Antioxidant defense 
prevents the formation of active oxygen radicals and lipoperoxides and the antioxidant 
capacity  decreases with  advancement  of  age.  This  increased  production  of  reactive 
oxygen species with age leads to oxidative damage and mutations in DNA molecules. 
These  damaged  molecules  transcribe  and  translate  to  produce  dysfunctional  protein 
subunits that give rise to defective enzymes. Normally the free radicals that are generated 
are disposed off quickly by antioxidant defence system (ADC) presenting cells. The ADS 
consists  of  free  radical  scavenging  enzymes  likeMnSOD,  Cu,  ZnSOD,  catalase  and 
antioxidants such as reduced glutathione (GSH), vitamin C, vitamin E, etc. An imbalance
FIG.4 - ROLE OF ANTIOXIDANT IN FREE RADICAL SCAVENGING
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 ROS  are  cleared  from  the  cell  by  the  action  of  superoxide  dismutase  (SOD), 
catalase, or glutathione (GSH) peroxidase and glutathione reductase. 
 The  main  damage  to  cells  results  from  the  ROS-induced  alteration  of 
macromolecules such as polyunsaturated fatty acids in membrane lipids, essential 
proteins, and DNA. 
 Additionally,  oxidative  stress  and ROS have  been implicated in  disease states, 
such as Alzheimer's disease, Parkinson’s disease, cancer, and hepatotoxicity. 
caused by increased generation of free radicals  and decreased functional efficiency of 
ADS has been suggested to be one of the primary factors that contribute to the aging 
process. (10)
Antioxidant defense  
   The rise in free radicals, associated with antioxidant deficiency is said to result in 
tissue damage this is possible due to effective low-molecular weight antioxidants (such as 
ascorbic  acid,  glutathione,  and  alpha-tocopherol)  as  well  as  high  molecular  weight 
antioxidants  (such  as  superoxide  dismutase,  glutathione  peroxidase  and  reductase, 
antioxidants are balanced with reactive oxygen species generation at  a level at which 
these compounds can play their physiological roles without any toxic effects (11). The 
antioxidant  defence  should  still  be  sufficient  to  challenge  the  excess  free  radical 
formation. It is  important to prevent the appearance of the oxidative reactions and their 
products.  .  The  OH+ and  O2+ radicals  are  the  active  oxygen  species  produced in the 
oxidative process, which oxidize lipids to lipid hydro peroxides and to lipid radicals. 
Catalase(12).  In  the normal  corneal  epithelium,  similarly as  in  other  tissues,  the  Cell 
defense  against  the  ROS  utilizes  antioxidant  enzymes  such  as  superoxide  dismutase 
(SOD), catalase, and glutathione peroxidase.Antioxidant defences can be classified into 
enzymatic (SOD, CAT, GPX, GR) and non-enzymatic (reduced glutathione, vitamin c) 
systems. 
D-GALACTOSAMINE 
                            
                             
Structure of D-Galactosamine Hydrochloride
D-galactosamine  chemically  called  as  (2-Amino-2-deoxy-D-galactose 
hydrochloride). 
           Molecular Formula -C6H13NO5.HCl;
           Molecular Weight   - 215.63
           Appearance             - White or Similar White Crystalline powder
The  mechanisms  underlying  the  hepatotoxicity  action  of  galactosamine  have  been 
extensively elucidated. Within 30 min of galactosamine administration in experimental 
animals (rats), there occurs a high accumulation of UDP-galactosamine derivatives in the 
liver, leading to a depletion of hepatic UTP. As a result biosynthesis of macromolecules 
(RNA, proteins, glycoprotein, glycogen, etc.) ceases. These alterations lead to eventual 
cell damage and cell death, which at later stages of the reaction may be identified by the 
FIGURE .5 - MOLECULAR MECHANISM OF D-GALACTOSAMINE IN LIVER 
increase of liver enzymes in the blood and by histology. The development of liver injury 
may be inhibited  through inhibition  of  the  early metabolic  alterations  by uridine.  D- 
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galactosamine  induced  hepatic  injury  is  similar  to  viral  hepatitis  (13,14).The 
galactosamine-induced  liver  injury  are  intimately  connected  with  alterations  in  the 
structure and function of the plasma membrane due to impaired membrane glycoprotein 
synthesis. Also, a role for complement has been recently suggested when it was shown 
that, in the galactosamine-injured rat, activated complement is fixed to the liver plasma 
membrane. Galactosamine is a specific hepatotoxicity agent, its effects being confined to 
the liver. Other organs or tissues are not affected. (15, 16). GAIN causes hepatic injury as 
indicating  by  sever  necrosis  and  widespread  micro-  and  macro-  steatosis  (fatty 
degradation) and both lobular and portal inflammation. Raised plasma AST activities and 
reduction in total protein, albumin and globulin fraction were also observed supporting 
the contention  that  metabolic  function of  the liver  were altering  by GAIN treatment. 
GAIN administration had been produces the MDA-protein adducts that reflective of lipid 
per  oxidation.  Previous  studies  had suggested that  the activation  of Kupffer  cells  are 
involved in the generation of protein adduct in the liver.
The Kupffer cells play an important role in the pathogenesis of GAIN induced 
injury (17, 18, and 19). D-galactosamine having a mechanism to produce the membrane 
damage  by  increasing  free  radicals  this  radicals  attack  the  lipids  present  in  the 
hepatocytes and generating the lipid peroxidation process (20).
ALPHA LIPOIC ACID 
 
Alpha-lipoic  acid  (1,  2-dithiolane-3-pentanoic  acid)  a  disulphide  derivative  of 
octanoic acid is known to act as an efficient antioxidant and metal-chelating agent (21) 
and it is commonly used as a dietary supplement and is found in abundance in animal 
tissues with high metabolic activity such as heart, liver and kidney and to a lesser extent 
in fruits and vegetable.
              
                                       Structure of Alpha Lipoic Acid 
Alpha Lipoic acid is an eight-carbon structure that contains a disulfide bond as 
part  of a  dithiolane ring with a five-carbon tail.  It  is  a cofactor  in  the conversion of 
pyruvate to acetyl  CoA as part  of the pyruvate dehydrogenase complex this  complex 
process is mainly helpful for mitochondrial energy metabolism. (22). 
 ALPHA LIPOIC ACID'S PHYSIOLOGICAL EFFECTS:
• Its a potent antioxidant that is both fat and water soluble 
• It helps to re-cycle vitamins C and E, and the antioxidant glutathione, thereby 
      prolonging their life span 
• ALA have a powerful anti-ageing effect 
•  Reduces the build up of fatty deposits on artery walls 
•  May help to control high blood pressure 
• May improve liver function 
• Improves insulin sensitivity, thereby helping to control blood sugar levels 
• Increases both fat and glucose metabolism 
• Decreases appetite 
• May help to decrease body fat 
• Increases glucose and creatine uptake within muscle cells 
• Improves recovery from injury 
• Improves mental function 
• It has no serious side effects 
   ALA is effective in the prevention and treatment of oxidative stress. Under 
oxidative  stress,  some  endogenous  protective  factors  such  as  GPx  and  catalase  are 
activated  in  the  defense  against  oxidative  injury  (23).Alpha  lipoic  acid  is  a  sulfur-
containing fatty acid found inside each and every body cell. ALA has a key role in the 
metabolism as it helps to convert glucose into cellular energy
Alpha-lipoic acid is a powerful antioxidant that helps cells convert glucose 
to energy, detoxifies the body, fights inflammation in the skin, and helps stabilize blood 
sugar.  Alpha-lipoic  acid  has  been called  a  "universal  antioxidant"  because  it  is  both 
water- and fat soluble, and thus can penetrate tissues composed mainly of fat, such as the 
nervous system, as well as those made mainly of water, such as the heart, to protect them 
from free-radical damage. Alpha-lipoic acid also helps the body use other antioxidants, 
such as vitamin E, vitamin C, and glutathione, more efficiently. This nutrient also helps B 
vitamins convert proteins, carbohydrates, and fats into energy more efficiently.  Alpha-
lipoic acid may be one of the most powerful  antioxidants discovered to date. It helps 
increase the body’s supply of glutathione, the most abundant natural antioxidant; so that 
free radicals are escorted out of the body before they can cause damage to cells. Free 
radicals have been shown to impair the immune system, leaving the body vulnerable to 
infections, heart disease, Liver injury and cancer. (24). Oxidation may also play a role in 
causing  poor  health  as  people  age,  and  some  researchers  claim  that  lipoic  acid  is 
beneficial  to maintaining good health  in  old age.  The nutrient  has been used to treat 
diabetic polyneuropathy,  a nerve disease found in many diabetics that cause pain and 
numbness  in  the  hands  and  feet.  In  addition  to  treating  nerve  damage  in  diabetics, 
researcher claim Alpha lipoic acid also lowers blood sugar levels as a therapeutic agent in 
a number of conditions related to liver disease, including alcohol induced damage (25)
Intracellular  GSH was positively  correlated    to  the  concentration  of  LA this 
compound also induces cystine uptake and can thereby increase glutathione synthesis. 
Alpha Lipoic acid has been shown to increase cellular GSH levels. A-Lipoic acid (LA) is 
a pro glutathione dietary supplement that is known to strengthen the antioxidant network. 
ALA supplementation protected against oxidative lipid damage in the heart, Liver and 
gastronomies muscle GSH homeostasis plays a central role in defending tissues against 
oxidative  stress.  Thus  it  is  important  to  understand  how  tissue  GSH  levels  may  be 
affected by ALA. It was previously shown that supplementation of GSH per se was not 
effective in increasing GSH levels in tissues, such as liver and muscle, that are known to 
be highly active in synthesizing GSH We observed that LA supplementation increased 
the GSH level of blood and liver ALA has   been shown to be involved in   the   recycling 
of   other   antioxidants   in   the   body including vitamins C and E and glutathione (26)  
Alpha-lipoic acid may prove useful in the treatment of hepatic injury because it relieves 
stress on the liver and helps rid the body of toxins. There have been several case reports 
of use of alpha-lipoic acid in combination with silymarin (milk thistle) and selenium (a 
substance with liver-protecting and antioxidant  properties) to help treat hepatitis  C (a 
serious type of hepatitis contracted from blood and bodily fluids that does not have an 
adequate cure or treatment). It has also been used in conjunction with silymarin to treat 
Amanita poisoning. Amanita is a highly poisonous mushroom that causes liver damage 
(27)  Alpha-lipoic acid supplements hold promise for treating various disorders, including 
HIV infection, liver ailments, and glaucoma. Alpha Lipoic acid shows evidence of being 
effective in the treatment of diabetic neuropathy and may be useful in treating some other 
aspects  of  diabetes.  In  addition  to  functioning  as  an  antioxidant,  this  hard-working 
nutrient assists the B vitamins in producing energy from the proteins, carbohydrates, and 
fats consumed through foods.
II. REVIEW OF LITERATURE
Han D, et al (1997) Alpha Lipoic acid increases de novo synthesis of cellular glutathione by 
improving cystine utilization. He had told that Lipoic acid (thiotic acid) is being used as a 
dietary supplement, and as a therapeutic agent, and is reported to have beneficial effects in 
disorders associated with oxidative stress. We present evidence that lipoic acid induces a 
substantial increase in cellular reduced glutathione in cultured human Jurkat T cells human 
erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocytes. 
The effect depends on metabolic reduction of lipoic acid to dihydrolipoic acid. Dihydrolipoic 
acid is released into the culture medium where it reduces cystine. Cystine thus formed is 
readily taken up by the  neutral  amino  acid  transport  system and utilized  for  glutathione 
synthesis.  By this  mechanism lipoic  acid  enables  cystine  to  bypass  the transport  system, 
which is weakly expressed in lymphocytes and inhibited by glutamate. Thereby lipoic acid 
enables the key enzyme of glutathione synthesis, gamma-glutamylcysteine synthetase, which 
is  regulated  by  uptake-limited  cysteine  supply,  to  work  at  optimum  conditions.  Flow 
cytometric  analysis  of  freshly  prepared  human  peripheral  blood  lymphocytes,  using 
monobromobimane  labeling  of  cellular  thiols,  reveals  that  lipoic  acid  acts  mainly  to 
normalize  a  subpopulation  of  cells  severely  compromised  in  thiol  status  rather  than  to 
increase  thiol  content  beyond  physiological  levels.  Hence  lipoic  acid  may  have  clinical 
relevance in restoration of severely glutathione deficient cells.
Atmaca G.  et al  (2004)  was explaining the antioxidant effect of sulfur-containing amino 
acids.  Sulfur  is  an  essential  element  for  the  entire  biological  kingdom  because  of  its 
incorporation  into  amino  acids,  proteins  and  other  biomolecules.  Sulfur  atoms  are  also 
important  in  the  iron-containing  flavoenzymes.  Unlike  humans,  plants  can  use  inorganic 
sulfur to synthesize sulfur-containing amino acids. Therefore, plants are an important source 
of  sulfur  for  humans.  Sulfur-containing  compounds  are  found  in  all  body  cells  and  are 
indispensable  for  life.  Some  of  sulfur-containing  antioxidant  compounds  are  cysteine, 
methionine,  taurine,  glutathione,  lipoic  acid,  mercaptopropionylglycine,  N-acetylcysteine, 
and the three major organ sulfur compounds of garlic oil, diallylsulfide, diallyldisulfide and 
diallyltrisulfide. In a comparison of the structure-function relationship among these sulfur-
containing antioxidant compounds, dihydrolipoic acid (the reduced form of LA) is the most 
effective antioxidant.  Dihydrolipoic acid contains two sulfhydryl  groups and can undergo 
further oxidation reaction to form lipoic acid. The antioxidative activities of sulfur-containing 
compounds follow a general trend, the more highly reduced forms are stronger antioxidants 
and the number of sulfur atoms determine, at least in part, their modulatory activites on the 
glutathione related antioxidant enzymes. 
Carey A. et al (2001) demonstrated the Alpha-Lipoic acid (LA) has antioxidant effects in 
humans and laboratory animals. The objective of this study was to determine whether the 
effects of ALA. Blood fractions of red and white blood cells (RBC and WBC, respectively)  
and plasma were analyzed for glutathione (GSH), glutathione peroxidase (GPx) and total 
plasma lipid hydroperoxides  (LPO). The results  show that  10 mg/kg LA had no evident 
adverse effects, and moderately reduced the oxidative stress of horses allowed light activity. 
These findings encourage studying of LA in horses subjected to strenuous exercise. 
Korda MM. et al(1996).Status of the antioxidant, monooxygenase and humoral immune system of the body in 
D-galactosamine hepatitis. This study states that Galactosamine model of toxic hepatitis in rats which, as to its  
morph biochemical picture, is considered adequate to human hepatitis was used to study the role of disturbances 
of the functional state of antioxidant and monooxygenase systems as well as humoral area of the systems of  
immune protection in pathogenesis of the given disease. It is shown that most components of enzymatic and 
nonenzymatic antioxidant system are considerably inhibited by the toxin effect. At the same time content of  
ceruloplasmin is increased in the blood plasma. Considerable disturbances are also observed in the humoral 
chain of the immune system (content of immunoglobulin and circulating immune complexes varies) and in the 
processes of microsomal oxidation.
Sun, F. et al (2003) Evaluation of oxidative stress during apoptosis and necrosis caused by D- galactosamine in 
rat liver. This study revels that the D-galactosamine causes apoptosis in the liver by activating caspase-3, which  
is released to the plasma by secondary necrosis. The concentration of lipid hydroperoxides in the liver increased  
significantly 24 hr after D-galactosamine administration. In contrast, the concentration of vitamin C in the liver  
decreased  significantly  18  and  24  hr  after  D-galactosamine  administration.  These  results  suggest  that  D-
galactosamine induces severe oxidative stress in the liver, leading to extensive necrosis.
III. SCOPE OF WORK 
The liver is an organ of paramount importance, which plays an essential role in 
the metabolism of foreign compounds entering the body. Human beings are exposed to 
these compounds through environmental exposure, consumption of contaminated food or 
during  exposure  to  chemical  substances  in  the  occupational  environment.  All  these 
chemicals  produce  a  variety  of  toxic  manifestations  in  liver  .Galactosamine  induced 
experimental model system in rats is recognized to be much like viral hepatitis in humans 
from both morphological and functional points of view . Galactosamine has great liver 
specificity  because  hepatocytes  have  high  levels  of  galactokinase  and  galactose-1-
uridyltransferase and does not affect other organs .Galactosamine causes hepatic injury 
with  spotty  hepatocytes  necrosis  and  marked  portal  and  parenchymal  infiltration. 
Galactosamine  also  causes  depletion  of  uridine  diphosphate  (UDP) by increasing  the 
formation  of  UDP-sugar  derivatives,  which  results  in  inhibition  of  RNA and  protein 
synthesis  leading  to  cell  membrane  deterioration.  Free  radicals  are  predominantly 
participating in pathogenesis of liver injury induced by GalN. .  Free radicals react with 
lipids and causes per oxidative changes that result in enhanced lipid peroxidation. GalN 
induces lipid peroxidation which is an auto oxidative process initiated by a variety of free 
radicals to which polyunsaturated fatty acids present in cell membranes are susceptible. 
ALA [5(1,  2-dithiolan-3-yl)  pentannoic acid,)]  is  a derivative of octanoic acid,  which 
form an intermolecular disulfide bond that can be reduced to form two highly reactive 
vicinal  sulfhydryl  groups.  As  is  generally  known  ALP  act  as  a  cofactor  which  is 
covalently  attached  to  the  lysine  residue  forming  an  essential  lipoamide,  which  is 
involved in  mitochondrial  energy metabolism.  Alpha Lipoic  acids  may improve  age-
related decline in memory and cognitive function and brain related ailments, including 
Alzheimer’s  disease  and  Parkinson’s  disease.  Lipoic  acid  and  its  reduced  form 
dihydrolipoic acid, reduce oxidative stress by scavenging a number of free radicals in 
both  membrane  and  aqueous  domains,  by  chelating  transition  metals  in  biological 
systems,  by preventing membrane lipid  peroxidation  and protein damage through the 
redox regeneration of other antioxidants such as vitamins C and E, and by increasing 
intracellular glutathione .ALA is utilize as a curative agent in number of condition related 
to liver diseases, together with alcohol induced liver damage, mushroom poisoning, metal 
intoxication and chloroform poisoning . LA aggravates the hepatic GSH levels due to the 
presence of  thiol  groups.  The free thiol  may be precursors  or  intermediates  in  GSH-
metabolism or foreign substances applied in medical treatments or science. The present 
study  is  designed  to  investigate  the  protective  nature  of  ALA  on  D-galactosamine 
induced  oxidative  mediated  DNA  damage  and  also  to  study  the  hepatoprotectivity, 
antioxidant activity of alpha lipoic acid on D-galactosamine induced oxidative stress.
IV.METHODOLOGY 
Drugs and chemicals
                           D-galactosamine and Alpha Lipoic acid were purchased from Sigma Aldrich 
Limited,  USA.  All  other  chemicals  and  solvents  used  were  of  the  highest  purity  and 
analytical grade.
 Animal model
                         This study was conduced using male albino Wistar rats (120-150).  
Animals were obtained from the Animal House, Vel’s College of Pharmacy, The Tamilnadu 
Dr. M.G.R. Medical University, and Chennai, India. Animals were fed with commercially 
available standard rat pelleted feed from M/s Hindustan Lever Limited,  Bangalore,  India. 
The feed and water were provided ad libitum. The animals were deprived of food for 24 h 
before experimentation but allowed free access to tap water throughout. The rats were housed 
under conditions of controlled temperature (25±2 0C) and were acclimatized to 12-h light: 12-
h dark cycles. Experimental animals were used after obtaining prior permission and handled 
according to the University and institutional legislation as regulated by the Committee for the 
Purpose of Control  and Supervision of  Experiments  on Animals  (CPCSEA), Ministry of 
Social Justice and Empowerment, Government of India.
EXPERIMENTAL PROTOCOL
   The experimental animals were randomized into four groups of six rats each as follows
Group 1: Control rats received normal saline (1 ml/kg, p.o.) for 7 days.
Group 2: Toxic control rats received normal saline (1ml/kg, p.o.) for 7 days        
Group 3: Drug control groups received Alpha lipoic acid (50 mg/kg, p.o.) for seven days
Group 4: Rats orally pretreated with Alpha lipoic acid (50 mg/kg, p.o.) for 7 days    
 Groups 2 and 4 also received GalN (500mg/kg, i.p.) on 7th day. 
After  24  hr  of  GalN  administration,  all  the  animals  were  anesthetized  and 
decapitated. Liver tissues were immediately excised and rinsed in ice cold physiological 
saline. Blood and tissue (liver) were instantly processed and used for various biochemical 
evaluations.
PREPARATION OF SERUM AND TISSUE HOMOGENATES
              Blood was collected and serum was separated by centrifugation at 3000 rpm for 
10 min for various biochemical estimations. Tissues (liver) were removed. Cleared off 
blood and immediately transferred to ice-cold container containing 0.9 NaCl for various 
estimations. A known amount of tissue was weighed and homogenized in Tris-Hcl (0.1M 
pH  7.4)  and  the  homogenate  was  used  for  the  estimation  of  different  biochemical 
parameters.
BIOCHEMICAL PARAMETERS
ESTIMATION OF LIVER MARKER ENZYMES 
            To evaluate the membrane damage, the activity of liver marker enzymes in serum 
was determined. 
Lactate dehydrogenase (LDH activity)  was assayed by the method of King et  
al, (1965a) (28).  About  1.0  ml  of  the  buffered  substrate,  0.1  ml  of  plasma/tissue 
homogenate was added and the tubes were incubated at 37.8ºC for 15 min. After adding 
0.2 ml of NAD+ solution, the incubation was continued for another 15 min. The reaction 
was arrested by adding 0.1 ml of DNPH (2, 4-dinitrophenyl hydrazine), and the tubes 
were incubated for a further period of 15 min at 37.8°C after which 7.0 ml of 0.4N NaOH 
was added and the color developed was measured at 420 nm. Suitable aliquots of the 
standards were also analyzed by the same procedure. The activity of the enzyme was 
expressed as μmoles of pyruvate liberated/min/mg protein.
Alanine  transaminase  (ALT) (1965b)  (29).About 1.0  ml  of  the  buffered 
substrate, 0.1 ml of plasma/tissue homogenate was added and the tubes were incubated at 
37.8ºC for 15 min. After adding 0.2 ml of NAD+ solution, the incubation was continued 
for  another  15  min.  The  reaction  was  arrested  by  adding  0.1  ml  of  DNPH  (2,  4-
dinitrophenyl hydrazine), and the tubes were incubated for a further period of 15 min at  
37.8°C after  which  7.0  ml  of  0.4N NaOH was  added  and  the  color  developed  was 
measured at 420 nm. Suitable aliquots of the standards were also analyzed by the same 
procedure.  The  activity  of  the  enzyme  was  expressed  as  μmoles  of  pyruvate 
liberated/min/mg protein.
Aspartate transaminase (AST) was estimated by the method of king (1965b). 1 
ml  of  buffered  substrate  was  incubated  at  37°C  for  10  minutes.  Then  0.2  ml  of 
plasma/tissue homogenate was added in the test tubes and incubated at 37°C for 1 hour. 
The reaction was arrested by adding 1.0 ml of DNPH reagent and tubes were kept at 
room temperature for 20 minutes. Then 10 ml of 0.4N sodium hydroxide solution was 
added. A set of pyruvic acid was also treated in a similar manner for the standard. The 
colour  developed was  read  at  520 nm against  the  reagent  blank.  The activity  of  the 
enzyme was expressed as μmoles of pyruvate liberated/min/mg protein.
Alkaline phosphatase (ALP) was estimated by the method of King (1965c). The 
incubation mixture contained the following compounds in a final volume of 3.0 ml of 
carbonate-bicarbonate buffer 1.0 ml of substrate and 0.1 ml of magnesium chloride and 
requisite amount  of the enzyme source (0.2 ml of serum).  The reaction mixture was 
incubated at 37ºC for 15 minutes. The reaction was terminated by the addition of 1.0 ml 
of. Folin”s phenol reagent. If turbidity appeared, the tubes were centrifuged. Controls 
without enzyme source were also incubated and the enzyme source was added after the 
addition of Folins phenol reagent.  Then 1.0 ml of 15% sodium carbonate solution was 
added and incubated further for 10 minutes at 37ºC.The blue colour developed was read 
at 640 nm against blank. The standards were also treated similarly. Their activities were 
expressed in terms of µmoles of pyruvate liberated h-1 mg-1 of protein.  Protein content 
was estimated by the method of Lowry et al, 1951, (31)
MEASUREMENT OF LIPID PEROXIDATION
Malondialdehyde (MDA) levels  in  liver  tissue homogenates  were determined 
spectrophotometrically  using  the  method  of  Buege  and  Aust  (32).  0.5  ml  of  tissue 
homogenate was shaken with 2.5 ml of 20% trichloroacetic acid in a 10 ml centrifuge 
tube. To the mixture, 1 ml of 0.67% thiobarbituric acid was added, shaken and warmed 
for 30 minutes in a boiling water bath followed by rapid cooling. Then 4 ml of n-butyl-
alcohol was added and shaken. The mixture was centrifuged at 3,000 rpm for 10 minutes. 
The resultant n-butyl-alcohol layer was taken and MDA content was determined from the 
absorbance at 535 nm. The results were expressed as nmol/g tissue. 
ESTIMATION OF ANTIOXIDANT ENZYMES
Superoxide dismutase (SOD) activity was analyzed by the method described by 
Rai et al, (33). Assay mixture contained 0.1ml of tissue homogenate, 1.2ml of sodium 
pyrophosphate buffer (pH 8.3; 0.052 M), and 0.1ml of phenazine methosulphate (186 
µm), 0.3ml of nitro blue tetrazolium, 300 µM, and 0.2ml of NADH (750µM). Reaction 
was started by addition of NADH. After incubation at 37°C for 90s, the reaction was 
stopped  by  addition  of  0.1ml  of  glacial  acetic  acid.  Reaction  mixture  was  stirred 
vigorously with 4.0ml of n-butanol.Colour intensity of the chromogenin the butanol was 
measured spectrophotometrically at 560 nm and concentration of SOD was expressed as 
U/mg.
Catalase (CAT) activity was measured by the method of Aebi  (34).0.1ml tissue 
homogenate was added to cuvette containing 1.9 ml of 50 mM phosphate buffers (pH 
7.0). Reaction was started by addition of 1.0ml of freshly prepared 30mM H2O2. The rate 
of decomposition of H2O2 was measured spectrophotometrically at 240 nm .Activity of 
catalase was expressed as U/mg of protein. 
Glutathione  peroxidase  (GPx) activity  was  determined  in  liver  homogenate 
according to the method of Lawrence and Burk (35). This method is based on measuring 
the oxidation  of reduced nicotinamide  adenine dinucletide  phosphate (NADPH) using 
hydrogen  peroxide  as  the  substrate.  A  reaction  mixture  of  1  ml  contained  50  mM 
potassium phosphate  buffer  (pH  7),  1  mM  EDTA,  1  mM  NaN3,  0.2  mM  NADPH, 
1Unit /ml oxidized glutathione reductase and 1mM GSH was prepared. The 0.1 ml of 
tissue homogenate was added to 0.8 ml of the reaction mixture and the solution was 
incubated for 5 minutes at 25oC. 0.1 ml of 0.25 mM hydrogen peroxide solution was 
added to initiate the reaction.  Absorbance was measured at 340 nm. The results were 
expressed as U/mg of protein. 
Glutathione reductase (GR) activity was assayed by the method of Carlberg and 
Mannervik  et al, (36). The assay system consisted of 1.65ml sodium phosphate buffer 
(0.1 M; pH7.4), 0.1ml EDTA (0.5 mM), and 0.05 ml oxidized glutathione (1 mM), 0.1ml 
NADPH (0.1 mM) and 0.05ml tissue homogenate in a total mixture of 2 ml. The enzyme 
activity was quantified by measuring the disappearance of NADPH at 340 nm at 30 Sec 
intervals for 3 min.The activity was expressed as nanomoles NADPH oxidized/min/mg 
protein.
ESTIMATION OF NON-ENZYMIC ANTIOXIDANTS
Reduced glutathione (GSH) activity  was determined  according  to  the 
methods of Ellman (37). The method is based on the reduction of Ellman’s reagent [5, 5’-
dithio-bs-(2  nitrobenzoic  acid)]  by  SH  groups  to  form  1mole  of  2-nitro-5-
mercaptobenzoic acid per mole of SH. The nitro-mercaptobenzoic acid has an intense 
yellow  color  and  can  be  determined  spectrophotmetrically.  To  0.5ml  of  10% 
trichloroacetic  acid.  6  mM  disodium  ethylene  diamine  tetra  acetic  acid,  0.5  ml  of 
homogenate  was  added and shaken  gently  for  10-15 minutes.  This  was  followed  by 
centrifugation at 2,000 rpm for 5 minutes. 0.2 ml of the supernatant was mixed with 1.7 
ml of 0.1M potassium phosphate buffer (pH 8). At least a duplicate was made for each 
sample.0.1 ml of Ellman’s reagent was added to each tube. After 5 minutes the optical 
density was measured at 412 nm against a reagent blank, the results were expressed as 
µmol/g tissue.
HISTOPHATHOLOGICAL EXAMINATION
 Tissue biopsies from the liver were fixed in 10% formal saline, subjected 
to  dehydration with  increasing  concentrations  of  ethanol  and  then  embedded  with 
paraffin wax. Following dehydration and embedding, histological sections were cut (5-7 
µm) with rotary microtome and the paraffin was washed off with three xylene baths,  
followed by three isopropanol baths, and rehydration. Finally, the section were stained 
with hematoxylin and eosin (H & E) and examined microscopically
DNA FRAGMENTATION STUDIES 
Liver tissues (100 mg) were treated with 100 mM Tris-HCl, 5 mM EDTA, 150 
mM sodium chloride and 0.5% sarkosyl, pH 8.0, at 4oC for 10 min. Then the samples 
were  processed  for  DNA  fragmentation  analysis  by  agarose  gel  electrophoresis  as 
described Herrmann  et al., (38). DNA extraction was performed using Quick Genomic 
DNA  Extraction  Kit  (GENE  LAB  biotechnology,  INDIA)  according  to  the  manual 
instructions.  The DNA pellet  was resuspended in TE buffer  (10 mmol/L Tris-HCI, 1 
mmol/L EDTA, pH 8.0) prior to loading (10 µl) onto a 1.5% agarose gel containing 0.5 
g/ml  ethidium  bromide.  Electrophoresis  was  conducted  at  35  Volts  for  4  h.  DNA 
fragments  were  visualized  and  photographed  under  UV  illumination.  DNA  marker 
(GENE LAB biotechnology, INDIA) was used to estimate the size of DNA fragment.
STATISTICAL ANALYSIS
 The results were expressed as mean ± standard deviation (S.D.) for six animals in 
each group. Differences between groups were assessed by one-way analysis of variance 
(ANOVA) using the SPSS 13.0 software package for Windows. Post hoc testing was 
performed for inter-group comparisons using the least significance difference (LSD) test; 
significance at P-values <0.001, <0.01, <0.05 have been given respective symbols in the 
tables.
V. RESULTS
Effect of Alpha lipoic acid on marker enzymes 
In the present study, intraperitoneal administration of a single dose of GalN (500 
mg/kg body weight) induced severe biochemical changes as well as oxidative injury in 
liver tissue. There was a significant (P < 0.05) rise in the levels of serum marker enzymes 
asparate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) 
and lactate dehydrogenase (LDH) in the serum of GalN administered (Group II) rats as 
compared to that of Group I control rats (Table I). The administration of ALA to Group 
IV animals restored the levels of these enzymes to near normalcy (P < 0.05) as compared 
to those Group II GalN-injected rats. In ALA alone administered rats (Group III) versus 
controls, no significant changes were observed.
Effect of Alpha lipoic acid on antioxidant enzymes 
Activities  of  endogenous  antioxidant  enzymes  such  as  superoxide 
dismutase(SOD),  catalase(CAT),  glutathioneperoxidase(GPx)  and  glutathione 
reductase(GR) was significantly (P < 0.05) lower in the liver tissue of Group II GalN-
injected rats as compared to that of Group I normal control rats (Table II). The observed 
reduction in the activities of GPx, GR in GalN-induced oxidative condition might be due 
to decreased availability GSH. In the present study, the treatment of Group IV rats with 
ALA, significantly (P < 0.05) reversed all these GalN-induced alterations in the activities 
of antioxidant enzymes (SOD, CAT, GPx and GR) to a near normal status. The normal 
rats  receiving  ALA  alone  (Group  III)  did  not  show  any  significant  change  when 
compared with control rats, indicating that it does not per se have any adverse effects.
Effect of Alpha lipoic acid on GSH and lipid peroxidation levels 
Intraperitoneal injection of GalN induced a significant (P < 0.05) increase in the 
level of LPO (Fig. 7), which was paralleled by significant (P <  0.05) reduction in the 
level of GSH (Fig.  6) in the liver  tissue of Group II  animals  as compared to normal 
controls. GSH plays an important role in the regulation of variety of cell functions and in 
cell protection from oxidative injury. Depletion of GSH results in enhanced LPO and due 
to this there is an increase in GSH consumption (38), as observed in the present study. In 
this study, the pretreatment with ALA (Group IV) significantly (P < 0.05) counteracted 
the GalN-induced LPO and restored the level of GSH to near normal level in Group IV 
rats as compared to that of Group II animals.
Histopathological examination
The  hepatoprotectivity  effect  of  ALA  was  confirmed  by  histopathological 
examination of the liver tissue of control and treated animals. Control liver shows normal 
architecture.  The  histological  architecture  of  GalN  treated  liver  sections  showed 
hepatocytes with centre lobular necrosis and inflammation. The histological of normal rat 
received ALA alone group does not show any structural differences when compare with 
control. Treatment group - administration of ALA (50 mg/kg) reduces the necrosis and 
inflammation had been produced by GalN induced toxicity which has been showing its 
potent hepatoprotectivity effects of ALA (Fig.8.A, B, C, and D)
DNA Fragmentation studies 
                           The effect of GalN on DNA damage in the rat liver and the protection 
rendered by alpha lipoic acid is presented in (Fig.9) The formation of DNA fragmentation 
occurs in GalN induced group (By Agarose Gel Electrophoresis) and alpha lipoic acid 
pretreatment significantly suppress the DNA damage induced by GalN.   
TABLE I: EFFECT OF ALPHA LIPOIC ACID AND D-GALACTOSAMINE ON THE 
ACTIVITIES OF LIVER MARKER ENZYMES IN SERUM
Groups AST(IU L-1)
ALT
(IU L-1)
ALP
(IU L-1)
LDH
(IU L-1)
Group I (Control) 78.13 ± 5.00 49.22 ± 5.22 76.19 ± 5.07 211.40 ± 5.21
Group II
(GalN) 616.36 ± 45.16a,* 553.96 ± 56.58 a,* 160.96 ± 12.44a,* 361.04 ± 30.19a,*
Group III
(ALA) 77.81 ±  5.04
 NS 49.04 ± 6.02 NS 76.07 ± 5.50 NS 210.52 ± 5.09 NS
Group IV
(GalN +LA) 81.52 ± 5.05 b,* 54.96± 6.15 b,* 81.59±5.96 b,* 220.42 ± 6.33 b,*
      Results are expressed as mean ± S.D. for 6 rats. Comparisons are made between:  a- Group I and 
      Group II; b-Group II and Group IV. NS- Group I and Group III.  
      *Statistically significant (P < 0.05); NS – non-significant.
TABLE II: EFFECT OF ALPHA LIPOIC ACID AND D-GALACTOSAMINE ON 
THE ACTIVITIES OF LIVER ENZYMIC ANTIOXIDANTS 
Results  are  expressed  as  mean  ±  S.D.  for  six  rats.  Units  -  SOD: U/mg protein,  CAT:  U/mg 
protein,   µmoles H2O2 consumed min−1 mg−1 protein. GPx: U/mg protein, µmoles GSH oxidized 
min−1 mg−1 protein. GR: nmoles NADPH oxidized min−1 mg−1 protein .Comparisons are made 
between: a-Group I and Group II; b-Group II and Group IV. NS- Group I and Group III.
* Statistically significant (P < 0.05); NS – non-significant.
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FIG.7: LEVELS OF MDA IN THE LIVER OF THE EXPERIMENTAL ANIMALS
                 Results are given as mean ± S.D. for six rats. Comparisons are made between: 
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FIG. 8 - HISTOLOGICAL EXAMINATION OF LIVER IN EXPERIMENTAL 
RATS
         A. CONTROL                                                                 B. GALN INDUCTION 
DRUG ALONE (ALA) 
TREATMENT (GALN + ALA)
FIG. 9 – EFFECT OF ALPHA LIPOIC ACID AND D-GALACTOSAMINE
IN DNA FRAGMENTATION
                                  Mar ker DNA    N.C   T.C   50 mg/kg
(GalN toxicity shows the centre lobular    
  necrosis and Inflammation) 100 x
(Normal architecture) 100 x 
(ALA alone does not shows any changes 
while compare with control tissue) 100 x 
(Pretreatment with ALA reduce the necrosis 
and inflammation when compare with toxic 
control) 100 x
1 LANE – MARKER DNA 
2 LANE – NORMAL CONTROL (Normal DNA BAND)
3 LANE – TOXIC CONTROL (Fragmented DNA BAND)
4 LANE – TREATMENT (ALA 50 mg/ kg) - (ALA treatment reduced the DNA
Fragment significantly when compare with toxic control)
VI. DISCUSSION
 GalN  induced  oxidative  stress  in  the  rat  liver  produces  the  imbalance  between 
biochemical processes leading to formation of reactive oxygen species and the cellular 
antioxidant  cascade,  causes  molecular  damage  that  can  lead  to  a  critical  failure  of 
biological functions and ultimately cell death (39,40 ,41).
                        At the course of liver injury, the transport function of hepatocytes is 
distressed  which  can  result  in  the  leakage  of  plasma  membrane,  thereby  causing  an 
increase  in  serum  marker  enzymes  like  AST,  ALT,  ALP  and  LDH  (42,  43).  GalN 
administration  in  rats  disrupts  the  membrane  permeability  of  the  plasma  membrane 
causing leakage of the enzymes from the cell, which leads to elevation in levels of marker 
enzymes (44). In this study the rise in AST, ALT, ALP and LDH levels induced by GalN 
administration  was  significantly  reduced  by  ALA  pretreatment  suggesting  that  its 
hepatoprotectivity activity might  be due its effect  against  cellular leakage and loss of 
functional integrity of the cell membrane in hepatocytes.  
 LPO distorted the levels of some free radical scavengers which indirectly reveals 
the oxidative stress in liver (45).LPO involves the direct reaction of oxygen and lipid to 
form radical intermediates and to produce semi stable peroxides, which in turn damage 
the  enzymes,  nucleic  acids,  membranes  and  proteins (46).  LPO  is  thought  to  be  an 
important  mechanism of  liver  injury  and  malondialdehyde  (MDA)  is  one  of  its  end 
products and measurement of MDA can be used to assess lipid peroxidation levels (47). 
It  has  been  well  documented  that  GalN  administration  produces  the  MDA-protein 
adducts which is reflective of lipid peroxidation (48).  Previous reports confirmed that 
ALA scavenges hydroxyl radicals; H2O2, singlet oxygen, superoxide radicals and peroxyl 
radicals  thereby  preventing  the  free  radicals  mediated  LPO (49).  In  this  study ALA 
pretreatment diminish the LPO end products, and protect the membrane damage caused 
by GalN. Earlier  reports have shown that LPO induced by GalN is concomitant  with 
GSH depletion (50). 
GSH is the intracellular  non-protein sulphydryl  compound that  supply as both 
nucleophile  and  an  effective  reductant  by  interacting  with  various  electrophilic  and 
oxidized  compounds  and  its  depletion  results  in  increased  defenselessness  of  cell  to 
oxidative  stress  (51,  52). The  consequence  of  decrease  in  cellular  GSH levels  is  an 
increase  of  free  radical  intermediates  leading  to  oxidative  stress  and  potent  cellular 
damage.  The reduced form of GSH becomes readily oxidized to oxidized glutathione 
(GSSG) with the GPx on interacting with free radicals  (53,  54). In the present study 
pretreatment of the rats with ALA significantly increased the concentration of GSH.  It 
had  been known that  the  ALA play  an  important  role  in  improving  the  GSH status 
through the mechanism of increasing the cystine availability, because the cystine is the 
rate-limiting factor in GSH biosynthesis.  ALA system induces the cystine uptake and 
thereby increasing GSH synthesis. In our present investigation pretreatment with ALA 
aggravates the hepatic GSH level which is in accordance with the previous studies (55).
 A  major  defense  mechanism in the human system  involves  the  antioxidant 
enzymes  including SOD, CAT and GPx which convert  active  oxygen  molecules  into 
non-toxic  compounds  which  includes  free  radical  scavengers  and  chain  reaction 
terminators  (56,  57).  CAT is  the  key  component  of  the  antioxidant  defense  system, 
inhibition of this protective mechanism leads to free radicals induced cellular damage. 
The observed decrease in the activity of CAT in oxidative stress is consistent with earlier 
studies (58, 59, and 60). ALA is able to increase glucose uptake in vitro (61). Enhanced 
glucose uptake by cells serve as a fuel for both the pentose phosphate shunt and oxidative 
phosphorylation, thus bringing up the cellular levels of nicotinamide adenine dinucleotide 
phosphate  (NADPH)  and  nicotinamide  adenine  dinucleotide  (NADH)  and  thereby 
enhances the activity of CAT in stress condition (62).  SOD is an enzyme extensively 
used as a biochemical indicator of pathological states associated with oxidative stress. At 
the first step of the defense system against oxidative stress, it catalyzes dismutation of the 
super oxide anion into hydrogen peroxide. H2O2 is one of the most active oxygen species, 
at  the  second  step  of  the  antioxidant  defense  system;  GPx  and  CAT  independently 
degrade  H2O2  to  water.  Several  lines  of  evidence  indicated  that  SOD activity  should 
therefore produce an excess H2O2 that must be efficiently neutralized by either GPx or 
CAT (63, 64). Our data indicated that GalN induced oxidative stress causes a significant 
inhibition of SOD and CAT. The possible reason for this finding could be the decrease of 
this enzyme caused by enhanced lipid peroxidation in the stress condition (65). On the 
other hand, declined SOD and CAT activity in liver tissues of GalN treated rats was 
brought back to a normal level with administration of ALA. The GPx which is coupled 
with GSH, together with catalase a major cellular reducer of hydrogen peroxide (66). The 
stress-induced decrease in the activity of GPx documented in our study is corroborated by 
earlier investigations (58, 59). GPx activity in the liver of stressed rats was also brought 
back  to  a  normal  level  with  administration  of  ALA.  GR  is  responsible  for  the 
transformation  of  the  GSSG  into  its  reduced  form  GSH,  the  diminution  in  the 
concentration  of GSH leads  to  fast  accumulation  of  lipid  peroxides  in  a  cell  (67). A 
decrease  in  the  activity  of  these  antioxidants  can  lead  to  an  excess  availability  of 
superoxide anion and hydrogen peroxide in biological systems, which in turn generate 
hydroxyl radicals, resulting in initiation and propagation of lipid peroxidation (68). ALA 
indirectly influence the activities of SOD apart from this the increases intercellular GSH 
content  might  also activate  the GSH-depended enzymes,  GPX thereby preventing the 
accumulation of H2O2  and  also increases the activity of CAT (69). The previous report 
shows that the decline in levels of antioxidant enzymes such as SOD, CAT, GR and GPx 
in GalN induced oxidative stress  (70, 71).  It has been demonstrated that treating with 
ALA increases the enzymes levels by directly react with various reactive oxygen species 
and also nullify the oxidation process in lipids and intercellular components (72). In our 
study pretreatment with ALA prevent the leakage of liver marker enzymes and increases 
the  levels  of  antioxidant  enzymes  and  thus  protect  the  liver  against  oxidative  stress 
induced by GalN. GalN is reported to produce necrosis and inflammatory infiltration in 
liver parenchyma and peripheral areas (14).In our study GalN administration produces 
the centre lobular necrosis and inflammation around the central vein area. Pretreatment 
with ALA protect liver from GalN induced histopathological changes.
Free-radicals  cause  many  damaging  effects  within  our  bodies,  including: 
interference with normal cellular processes, damage to cell membranes and structures, 
damage  and breakage of  DNA strands.  GalN induced ROS generation  which  in  turn 
increases the apoptosis mechanism and thus the DNA damage occurs. In addition to this 
mechanism of GalN induced DNA damage is due to the fact of increase in intracellular 
concentration  of  calcium  and  there  is  also  an  increase  in  levels  of  proinflammatory 
cytokines (TNF-α) which mediate the necrotic process (73). In this study pretreatment 
with lipoic acid significantly prevents the DNA damage induced by GalN which is in line 
with earlier reports (74)
VII. SUMMARY AND CONCLUSION
Alpha lipoic acid is “Multi functional Antioxidant”. It protects cell membrane 
from  free  radical  attack,  augments the  body’s  entire  antioxidant  network  including 
glutathione & coenzyme Q10, directly and indirectly reduces DNA damage, it improves 
mitochondrial antioxidant on oxidative condition,  and ALA is an  important antioxidant 
that  helps  to  recycle  other  non-enzymic  antioxidants  (Vitamin  C,  E,  and  Reduced 
glutathione) to fight against fat-soluble and water-soluble free radical attacks. 
D-galactosamine  induction  had  been  drastically  increase  the  serum  marker 
enzymes  levels  (AST,  ALT,  ALP,  LDH) this  has  been  clearly  shows the  membrane 
damage in hepatocytes  but in this study pre-treatment with alpha lipoic acid significantly 
reduce the marker enzymes levels in serum thus the hepatoprotectivity activity might be 
due to the membrane stabilising action  of  ALA.
Liver is exposed to potent drugs and toxic chemical (D-galactosamine) which has 
been produces the free radicals very rapidly that free radical assault the lipids present in 
the hepatocytes and this condition instantly leads to lipid peroxidation which exhibit the 
byproduct  called MDA. So lipid peroxidation effect is measuring by MDA levels. In our 
study GalN administration generating the free radicals and increase the lipid peroxidation 
levels but pre treatment with alpha lipoic acid significantly reduces the lipid peroxidation 
by scavenging the superoxide, hydroxyl, peroxyl radicals; single oxygen radicals by this 
mechanism ALA weaken the d-galactosamine induced lipid peroxidation.
In this study GalN induced lipid peroxidation significantly decline the GSH levels 
because rapid production of lipid peroxidation are effectivelely counteracted by GSH but 
the fast generation of radicals completely reduces the GSH concentration in tissue and 
also  reduces  the  enzymic  antioxidant  levels  but  pre  treatment  with  alpha  lipoic  acid 
increase the GSH level in tissue this can be occur by increasing the cysteine availability 
enhancer like ALA because cysteine is rate limiting enzyme in inter cellular GSH  bio 
synthesis. 
ROS are scavenged by antioxidant enzymes like SOD, CAT, GPX,  and GR.ALA 
ultimately  influence  on  SOD  apart  from  increasing  the  GSH  levels.  SOD  primary 
antioxidant  enzymes  which  has  been directly  converts  the  singlet  oxygen  radicals  to 
hydrogen peroxide in the second step CAT and GPx involved to convert the hydrogen 
peroxide  in  to  water  and oxygen.  GR not  having any specific  action  but  its  help  to 
convert the oxidised glutathione in to reduce one. In this study GalN injection markedly 
reduces the enzymic antioxidant levels but pre treatment with alpha lipoic acid improving 
the antioxidant enzymes which clearly exemplifies the antioxidant potency of ALA.
Histopathological observation reveals thus the GalN induction group shows centre 
lobular necrosis with severe inflammation in tissue which has been effectively reduce in 
ALA treatment group.
In this study GalN administration cause DNA fragmentation which indicates the 
cell death process this is due to the generation of free radicals. Pre-treatment with alpha 
lipoic acid effectively reduces the DNA damage by scavenging the ROS generated by 
GalN. 
In Conclusion,  the results  of  this  study demonstrate  that  the administration  of 
GalN induced extensive oxidative  stress in  liver,  which is  associated  with membrane 
damage and hepatocytes dysfunction. ALA supplementation may reduce oxidative stress 
in liver of GalN treated rats by decreasing the lipid peroxidation and ROS propagation by 
scavenging  free  radicals,  or  by  improving  the  actions  of  antioxidant  enzymes.  The 
function  of  ALA  in  the  regulation  of  GSH  and  intercellular  antioxidant  may  be 
significant in the restitution of redox status and it reduces the DNA damage induced by 
GalN administration. 
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